Your browser doesn't support javascript.
loading
Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.
Eissa, Hesham; Thakar, Monica S; Shah, Ami J; Logan, Brent R; Griffith, Linda M; Dong, Huaying; Parrott, Roberta E; O'Reilly, Richard J; Dara, Jasmeen; Kapoor, Neena; Forbes Satter, Lisa; Chandra, Sharat; Kapadia, Malika; Chandrakasan, Shanmuganathan; Knutsen, Alan; Jyonouchi, Soma C; Molinari, Lyndsay; Rayes, Ahmad; Ebens, Christen L; Teira, Pierre; Dávila Saldaña, Blachy J; Burroughs, Lauri M; Chaudhury, Sonali; Chellapandian, Deepak; Gillio, Alfred P; Goldman, Fredrick; Malech, Harry L; DeSantes, Kenneth; Cuvelier, Geoff D E; Rozmus, Jacob; Quinones, Ralph; Yu, Lolie C; Broglie, Larisa; Aquino, Victor; Shereck, Evan; Moore, Theodore B; Vander Lugt, Mark T; Mousallem, Talal I; Oved, Joeseph H; Dorsey, Morna; Abdel-Azim, Hisham; Martinez, Caridad; Bleesing, Jacob H; Prockop, Susan; Kohn, Donald B; Bednarski, Jeffrey J; Leiding, Jennifer; Marsh, Rebecca A; Torgerson, Troy; Notarangelo, Luigi D.
Afiliación
  • Eissa H; Division of Pediatric Hematology-Oncology-BMT, University of Colorado, Aurora, Wash. Electronic address: Hesham.eissa@cuanschutz.edu.
  • Thakar MS; Fred Hutchinson Cancer Center, Seattle, Wash; Department of Pediatrics, University of Washington, Seattle, Wash.
  • Shah AJ; Pediatrics [Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine], Stanford University/Lucille Packard Children's Hospital, Palo Alto, Calif.
  • Logan BR; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wis.
  • Griffith LM; Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Md.
  • Dong H; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wis.
  • Parrott RE; Duke University Medical Center, Durham, NC.
  • O'Reilly RJ; Department of Pediatrics, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Dara J; Division of Allergy, Immunology and Blood and Marrow Transplantation, Department of Pediatrics, University of California San Francisco School of Medicine and UCSF Benioff Children's Hospital, San Francisco, Calif.
  • Kapoor N; Division of Hematology, Oncology and Blood and Marrow Transplant, Children's Hospital Los Angeles, Los Angeles, Calif.
  • Forbes Satter L; Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, Tex.
  • Chandra S; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio.
  • Kapadia M; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Mass.
  • Chandrakasan S; Bone Marrow Transplantation and Immune Deficiency, Children's Healthcare of Atlanta, Atlanta, Ga.
  • Knutsen A; St Louis University, Cardinal Glennon Children's Hospital, St Louis, Mo.
  • Jyonouchi SC; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
  • Molinari L; Methodist Children's Hospital of South Texas, San Antonio, Tex.
  • Rayes A; Division of Hematology, Oncology, Transplantation, and Immunology, Primary Children's Hospital, Huntsman Cancer Institute, Spense Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah.
  • Ebens CL; Division of Pediatric Blood and Marrow Transplant and Cellular Therapy, University of Minnesota Masonic Children's Hospital, Minneapolis, Minn.
  • Teira P; Paediatric Haematology Oncology, Ste-Justine Hospital, Montreal, Canada.
  • Dávila Saldaña BJ; Children's National Hospital, Washington, DC.
  • Burroughs LM; Fred Hutchinson Cancer Center, Seattle, Wash; Department of Pediatrics, University of Washington, Seattle, Wash.
  • Chaudhury S; Hematology, Oncology, Neuro-oncology & Stem Cell Transplantation Division, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
  • Chellapandian D; Center for Cell and Gene Therapy for Non-malignant Conditions, Johns Hopkins All Children's Hospital, St Petersburg, Fla.
  • Gillio AP; Children's Cancer Institute, Hackensack University Medical Center, Hackensack, NJ.
  • Goldman F; Division of Pediatric Hematology and Oncology and Bone Marrow Transplant, University of Alabama at Birmingham, Birmingham, Ala.
  • Malech HL; Genetic Immunotherapy Section, NIAID, NIH, Bethesda, Md.
  • DeSantes K; Division of Pediatric Hematology-Oncology & Bone Marrow Transplant, University of Wisconsin, American Family Children's Hospital, Madison, Wis.
  • Cuvelier GDE; Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, Winnipeg, Canada.
  • Rozmus J; Children's & Women's Health Centre of British Columbia, Vancouver, Canada.
  • Quinones R; Division of Pediatric Hematology-Oncology-BMT, University of Colorado, Aurora, Wash.
  • Yu LC; Division of Heme-Onc/HSCT, Children's Hospital/LSUHSC, New Orleans, La.
  • Broglie L; Department of Pediatrics, Division of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Medical College of Wisconsin, Milwaukee, Wis.
  • Aquino V; Division of Pediatric Hematology and Oncology, The University of Texas Southwestern Medical Center, Dallas, Tex.
  • Shereck E; Division of Pediatric Hematology/Oncology, Oregon Health and Science University, Portland, Ore.
  • Moore TB; Department of Pediatric Hematology-Oncology, Mattel Children's Hospital, University of California, Los Angeles, Calif.
  • Vander Lugt MT; Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Mich.
  • Mousallem TI; Duke University Medical Center, Durham, NC.
  • Oved JH; Department of Pediatrics, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Dorsey M; Division of Allergy, Immunology and Blood and Marrow Transplantation, Department of Pediatrics, University of California San Francisco School of Medicine and UCSF Benioff Children's Hospital, San Francisco, Calif.
  • Abdel-Azim H; Division of Hematology, Oncology and Blood and Marrow Transplant, Children's Hospital Los Angeles, Los Angeles, Calif; Loma Linda University School of Medicine, Cancer Center, Children Hospital and Medical Center, Loma Linda, Calif.
  • Martinez C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, Tex.
  • Bleesing JH; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio.
  • Prockop S; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Mass.
  • Kohn DB; University of California, Los Angeles, Calif.
  • Bednarski JJ; Department of Pediatrics, Washington University School of Medicine, St Louis, Mo.
  • Leiding J; Orlando Health Arnold Palmer Hospital for Children, Orlando, Fla.
  • Marsh RA; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio.
  • Torgerson T; Allen Institute for Immunology, Seattle, Wash.
  • Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, Md.
J Allergy Clin Immunol ; 153(1): 287-296, 2024 01.
Article en En | MEDLINE | ID: mdl-37793572

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Guideline Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Clinical_trials / Guideline Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos